73 related articles for article (PubMed ID: 10503259)
1. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies.
Delahunt B
Pathology; 1999 Aug; 31(3):185-90. PubMed ID: 10503259
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
3. The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review.
Wei S; Al-Saleem T
J Kidney Cancer VHL; 2017; 4(2):19-23. PubMed ID: 28725540
[TBL] [Abstract][Full Text] [Related]
4. Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma.
Kapur P; Zhong H; Le D; Mukhopadhyay R; Miyata J; Carrillo D; Rakheja D; Rajaram S; Durinck S; Modrusan Z; Brugarolas J
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38775158
[TBL] [Abstract][Full Text] [Related]
5. Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Hahn AW; Surasi DS; Viscuse PV; Bathala TK; Wiele AJ; Campbell MT; Zurita AJ; Shah AY; Jonasch E; Gao J; Goswami S; Alhalabi O; Rao P; Sircar K; Tannir NM; Msaouel P
Oncologist; 2024 May; 29(5):392-399. PubMed ID: 38035767
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma.
Zuo Y; Fu S; Zhao Z; Li Z; Wu Y; Qi T; Zheng J; Du Q; Xu Z; Yu N
Front Genet; 2022; 13():985641. PubMed ID: 36159988
[TBL] [Abstract][Full Text] [Related]
7. The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis.
Al-Juhaishi T; Deng X; Bandyopadhyay D; Paul A
Cureus; 2022 May; 14(5):e25395. PubMed ID: 35774668
[TBL] [Abstract][Full Text] [Related]
8. Feline sarcomatoid renal cell carcinoma with peritoneal carcinomatosis and effusion.
Wu B; Kastl B; Cino-Ozuna AG; Springer NL; Thakkar R; Biller D; Whitehouse W; Easterwood L; Nguyen TA
J Vet Diagn Invest; 2022 Jan; 34(1):153-159. PubMed ID: 34713776
[TBL] [Abstract][Full Text] [Related]
9. Pathological eradication of recurrent metastatic renal cell carcinoma with sarcomatoid component by nivolumab plus ipilimumab combination therapy.
Sejima T; Masago T; Yoshida M; Nishi T; Kawabata Y; Tajima Y; Yumioka T; Honda M; Takenaka A
Int Cancer Conf J; 2021 Oct; 10(4):285-289. PubMed ID: 34567939
[TBL] [Abstract][Full Text] [Related]
10. Sarcomatoid renal cell carcinoma: biology, natural history and management.
Blum KA; Gupta S; Tickoo SK; Chan TA; Russo P; Motzer RJ; Karam JA; Hakimi AA
Nat Rev Urol; 2020 Dec; 17(12):659-678. PubMed ID: 33051619
[TBL] [Abstract][Full Text] [Related]
11. Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial.
Rini BI; Motzer RJ; Powles T; McDermott DF; Escudier B; Donskov F; Hawkins R; Bracarda S; Bedke J; De Giorgi U; Porta C; Ravaud A; Parnis F; Grande E; Zhang W; Huseni M; Carroll S; Sufan R; Schiff C; Atkins MB
Eur Urol; 2021 May; 79(5):659-662. PubMed ID: 32654802
[TBL] [Abstract][Full Text] [Related]
12. Recurrent metastatic clear cell renal carcinoma with sarcomatoid dedifferentiation treated with surgery and Cabozantinib.
Boustany J; Abdessater M; Hachem CE; Khoury ZE; Khoury WE; Khoury RE
Oncotarget; 2020 May; 11(20):1922-1928. PubMed ID: 32499875
[TBL] [Abstract][Full Text] [Related]
13. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
[TBL] [Abstract][Full Text] [Related]
14. Retrospective review of experience with sarcomatoid renal cell carcinoma: Multimodality treatment remains an unmet goal.
Kondisetty G; Borkar PV; Kondisetty S; Thomas A
Urol Ann; 2019; 11(4):385-388. PubMed ID: 31649458
[TBL] [Abstract][Full Text] [Related]
15. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.
Frascà GM; Brigante F; Volpe A; Cosmai L; Gallieni M; Porta C
J Nephrol; 2019 Feb; 32(1):57-64. PubMed ID: 30328092
[TBL] [Abstract][Full Text] [Related]
16. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies.
Warren AY; Harrison D
World J Urol; 2018 Dec; 36(12):1913-1926. PubMed ID: 30123932
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components.
Manley BJ; Hsieh JJ
Transl Cancer Res; 2016 Aug; 5(Suppl 2):S160-S165. PubMed ID: 29167760
[No Abstract] [Full Text] [Related]
18. Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma.
Maiti A; Nemati-Shafaee M; Msaouel P; Pagliaro LC; Jonasch E; Tannir NM; Shah AY
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28870517
[TBL] [Abstract][Full Text] [Related]
19. The ISUP system of staging, grading and classification of renal cell neoplasia.
Samaratunga H; Gianduzzo T; Delahunt B
J Kidney Cancer VHL; 2014; 1(3):26-39. PubMed ID: 28326247
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
